• Affiliate Assistant Professor, Global Health
  • Senior Epidemiologist and Implementation Scientist, RTI International
Barrot Lambdin

Pangaea Global AIDS Foundation
436 Fourteenth Street, Suite 920
Oakland, CA 94612
United States

Phone Number: 
415-848-1334
Fax: 
Email: 
blambdin@rti.org
Select from the following:
Biography 

Barrot H. Lambdin is a Senior Epidemiologist and Implementation Scientist within the Community Health and Implementation Research Program at RTI International. He is also an assistant adjunct professor within the Department of Epidemiology and Biostatistics at the University of California, San Francisco, and an affiliate assistant professor within the Department of Global Health at the University of Washington.

For more than 15 years, Dr. Lambdin has led implementation science initiatives throughout the world that have identified determinants and tested strategies to advance the implementation of evidence-based interventions in healthcare settings. These initiatives have included naloxone distribution in syringe service programs and supervised consumption services in the United States, opioid treatment in Tanzania, as well as HIV prevention and treatment in Tanzania, Zambia, Mozambique, Zimbabwe, and the United States. Most recently, he has served as the principal investigator on a number of NIH-funded initiatives to optimize our nation’s efforts to reduce opioid overdose fatalities and improving opioid treatment and HIV treatment delivery for people who use drugs in Tanzania.

Education 
  • PhD (University of Washington)
  • MPH (Emory University)
Health Topics 
  • Adult Mortality
  • Epidemiology
  • Hepatitis
  • HIV/AIDS
  • Leadership and Organizational Development
  • Quality Improvement
  • Tobacco, Alcohol, and Drug Use
  • Workforce
DGH Centers, Programs and Initiatives and Affiliated Organizations 
Publications 

Lambdin B.H., Bluthenthal RN, Wenger LD, Wheeler E, Garner B, Lakosky P, Kral AH. Overdose Education and Naloxone Distribution within Syringe Service Programs – United States, 2018. MMWR Morb Mortal Wkly Rep. 21 Aug 2020

Kral AH, Lambdin B.H., Wenger LD, Davidson PJ. Evaluation of an Unsanctioned Safe Consumption Site in the United States. N Eng J Med. 2020 Aug 6; 383(6):589-590.

Lambdin B.H., Bluthenthal RN, Zibbell JE, Wenger L, Simpson K, Kral AH. Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs. Int J Drug Policy. 2019 Dec;74:299-304

Kurth, A., Cherutich, P., Conover, R., Chun, N., Bruce, R.D., Lambdin, B.H., (2018) The Opioid Epidemic in Africa and Its Impact. Current Addiction Reports, 5(4), 428-53.

Lambdin, B. H., Davis, C. S., Wheeler, E., Tueller, S., & Kral, A. (2018, May). Naloxone laws facilitate the establishment of overdose education and naloxone distribution programs in the United States. Drug and Alcohol Dependence;188:370-376. DOI: 10.1016/j.drugalcdep.2018.04.004.